The biggest swings over the chart's period, each with the headlines about the market's subject published in the hours before it. News and odds moving together is not proof one caused the other.
Every outcome
Outcome
Chance
Day
Bid
Ask
Pays
Contracts
Foundayo
95%
93¢
96¢
$1.04
462
Omvoh
90%
▲ 34
78¢
89¢
$1.12
733
Jaypirca
90%
▼ 1
86¢
93¢
$1.08
663
Inluriyo
87%
84¢
90¢
$1.11
644
LillyDirect
86%
▲ 6
82¢
90¢
$1.11
690
Alzheimer
85%
▼ 1
81¢
88¢
$1.14
128
Vial
61%
▼ 2
57¢
65¢
$1.54
244
Headwind
47%
▲ 2
42¢
52¢
$1.92
53.00
ESMO
43%
▼ 1
39¢
47¢
$2.13
24.00
AI / Artificial Intelligence
34%
30¢
37¢
$2.70
406
Tariff
28%
25¢
32¢
$3.13
62.00
Tailwind
25%
20¢
30¢
$3.33
126
China (5+ times)
18%
16¢
20¢
$5.00
65.00
Pennsylvania
13%
10¢
15¢
$6.67
65.00
Nvidia
12%
7¢
17¢
$5.88
59.00
Ventyx
10%
5¢
15¢
$6.67
Novo Nordisk
7%
▲ 1
3¢
10¢
$10.00
65.00
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
Eli Lilly Joins Moonwalk’s $70M Series B Roundgenomeweb.com · 8 h agoMoonwalk Biosciences said it will use the funds to advance its lead candidate for obesity, MW101, into clinical testing by late 2027. Eli Lilly Joins Moonwalkâs $70M Series B Round to Fund Cardiometabolic RNAi Drugs NEW YORK â Moonwalk…
Eli Lilly (LLY) Reports Strong Phase 1 Ovarian Cancer DataYahoo Finance · 27 h agoEli Lilly (NYSE: LLY) reported new Phase 1 data for Sofe-M plus bevacizumab in platinum-sensitive ovarian cancer patients. The regimen showed a high confirmed response rate and disease control rate in both PARP inhibitor-experienced and…
Eli Lilly and Company $LLY Stock Holdings Raised by XXI Wealth LLCMarkets Daily · 8 h agoPosted by Kim Johansen on Oct 26th, 2026 Check Out Our Latest Analysis on LLY Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company that discovers, develops, manufactures and markets medicines for a range of medical…
Eli Lilly (LLY) Stock: Olomorasib Shows 62% Response Rate in Lung Cancer DataCoinCentral · 8 h agoEli Lilly (LLY) shared new lung cancer data on Sunday. The company presented results for its experimental drug olomorasib at the 2026 European Society for Medical Oncology congress in Madrid. The release did not include a stock price move…
Eli Lilly Stock Gets a Lift as New Lung Cancer Data Raises HopesYahoo Finance · 17 h agoEli Lilly (NYSE:LLY) shares climbed nearly 1% in pre-market trading after clinical data showed its experimental drug olomorasib shrank tumors in 62% of patients when paired with immunotherapy and chemotherapy for an aggressive form of lung…
Eli Lilly reports promising lung cancer drug resultsSeeking Alpha · 39 h agoLilly’s olomorasib showed promising lung cancer trial results, boosting its KRAS G12C treatment outlook ahead of key Phase 3 data. jetcityimage/iStock Editorial via Getty Images Eli Lilly (LLY) reported encouraging results from clinical…
3 Massive Catalysts That Could Ignite an Eli Lilly Stock Rally on Oct 2924/7 Wall St. · 27 h agoEli Lilly (NYSE:LLY | LLY Price Prediction) reports third-quarter results on October 29. It brings a streak of 5 consecutive EPS beats and a stock that has run hard into the report. I’m watching three catalysts that could keep the rally…
Abu Dhabi lures Eli Lilly, Oura, and Whoop in healthcare pushsemafor.com · 4 days agoMubadala Bio signed a deal with US drugmaker Eli Lilly during the Future Health Summit this week to package and distribute GLP-1 drugs locally. Abu Dhabi is betting big on GLP-1 drugs and wearables as it seeks to retool its healthcare…
Eli Lilly (LLY) Stock: Lung Cancer Drug Olomorasib Posts 62% Response Rate at ESMOMoneyCheck · 4 h agoEli Lilly (LLY) put fresh lung cancer data on the table Sunday at the European Society for Medical Oncology congress in Madrid. The focus was olomorasib, its experimental KRAS G12C inhibitor. Eli Lilly and Company, LLY One study tested the…
Eli Lilly releases promising early-stage data on ADC for ovarian cancerSeeking Alpha · 2 days agoPhase 1 data show Eli Lilly’s Sofe-M plus Avastin delivered strong ovarian cancer response rates across FRα levels. Read more here. - Phase 1 data on Eli Lilly's (LLY) sofetabart mipitecan (Sofe-M) found that the antibody-drug conjugate…
Eli Lilly and Company $LLY Stock Purchased by Crossmark Global Holdings Inc.Defense World · 2 days agoGet Our Latest Stock Report on Eli Lilly and Company Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company that discovers, develops, manufactures and markets medicines for a range of medical conditions. Its major therapeutic…
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Conservative. Prices read from the venues 2 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Conservative, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Conservative index; prices of stocks, rates and coins from 4Conservative Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions
